Cargando…
Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquine
INTRODUCTION: In early 2020, the coronavirus disease 2019 (COVID-19) pandemic spread worldwide, overwhelming hospitals with severely ill patients and posing the urgent need for clinical evidence to guide patient care. First treatment options available were repurposed drugs to fight inflammation, coa...
Autores principales: | Wüstner, Stefanie, Hogger, Sara, Gartner-Freyer, Daniela, Lebioda, Andrea, Schley, Katharina, Leverkus, Friedhelm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896497/ https://www.ncbi.nlm.nih.gov/pubmed/35252090 http://dx.doi.org/10.3389/fpubh.2022.804404 |
Ejemplares similares
-
SA14 Clinical Evidence on Corticosteroid Treatment Reported in the First Year of the COVID-19 Pandemic – Comparison of Clinical Trial Publications and Treatment Recommendation
por: Wüstner, S, et al.
Publicado: (2022) -
Biomimetic properties and estimated in vivo distribution of chloroquine and hydroxy-chloroquine enantiomers
por: Valko, Klara L, et al.
Publicado: (2020) -
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020) -
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
por: Lei, Zi-Ning, et al.
Publicado: (2020) -
Chloroquine for Covid 19: introducing drug repurposing to medical students
por: Koren, Gideon, et al.
Publicado: (2020)